Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov;269(11):2349-54.
doi: 10.1007/s00405-012-1935-5. Epub 2012 Jan 24.

Clinical and histologic features of inverted papilloma-associated malignancy

Affiliations

Clinical and histologic features of inverted papilloma-associated malignancy

Jin Woong Choi et al. Eur Arch Otorhinolaryngol. 2012 Nov.

Abstract

The objectives of the study were to analyze the clinical features of inverted papillomas (IP) associated with malignancy and to evaluate the correlation of tumor stage, survival and histolologic features. We conducted a retrospective review of 18 IP associated with malignancy patients. In addition, we compared histopathologic characteristics (tumor differentiation and malignant cell proportion) with clinical outcomes. Eleven of the tumors were present on the nasal cavity and 7 on the maxillary sinus. The rates of synchronous and metachronous malignancy were 10.1 and 1.1%, respectively. The disease-free survival rate was 83.3%. The tumors were staged as T1 (5/18), T2 (2/18), T3 (8/18), and T4 (3/18). According to the percentage of the malignant cell in the entire tumor tissue, 4 patients (22%) were in grade I, 4 patients (22%) were in grade II, 3 patients (17%) were in grade III, and 7 patients (39%) were in grade IV. There was no relationship between recurrence- and/or disease-free survival and histologic findings including tumor differentiation and malignant proportion. IP-associated malignancy tends to occur synchronously and have more favorable prognosis compared to other sinonasal malignancy. Furthermore, the proportion of malignant cell to IP and tumor stage seems not to affect the clinical outcome of IP-associated malignancy.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Neuroradiology. 2009 Apr;51(4):265-71 - PubMed
    1. Mod Pathol. 2002 Mar;15(3):279-97 - PubMed
    1. J Clin Oncol. 2007 Oct 20;25(30):4848-50 - PubMed
    1. Ann Nucl Med. 2004 Feb;18(1):29-34 - PubMed
    1. Ann Surg Oncol. 2010 Jun;17(6):1471-4 - PubMed

LinkOut - more resources